A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

"As temperatures rise, cancer mortality among women also rises -- particularly for ovarian and breast cancers," lead ...

Cancer can manifest in various ways, and early detection is crucial for effective treatment. As per the American Cancer ...

A “breakthrough” new three-drug combination offers hope for women battling an aggressive form of breast cancer, potentially ...

Lily Murphy was first diagnosed with melanoma at 23 years old while working at an NHS hospital’s dermatology department ...

It is the first worldwide study to show that using blood tests to find early signs of cancer resistance to treatment helps ...

Long-term results from the Women’s Health Initiative have revealed associations between cancers and hormone therapy, supplements, diet, BMI, metabolic syndrome, and NSAIDs.

A trial funded by AstraZeneca found the drug is effective in stopping cancer cells from using hormones to grow ...

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests.

The number of cancer survivors living in the United States is continuing its steady increase, rising to an estimated at 18.6 ...